Researchers from the Gladstone Institutes have developed a potential treatment for Type 1 diabetes by differentiating stem cells into insulin-producing pancreatic beta cells. These new cells, when transplanted into animal models, lowered abnormally high glucose levels down to a more healthy level in just one week. Continue reading
A team of researchers from the University of Michigan and the University of Emory reported positive results from a phase 1 clinical study utilizing stem cells to treat amyotrophic lateral sclerosis [ALS], Lou Gehrig’s disease. In addition to verifying the safety of the new procedure, the trial revealed some progress in preventing further disease damage to the motor nerves by improving their cellular environment. Continue reading
In a recent Phase II clinical study, researchers report that mesenchymal stem cells were successful in relieving chronic lower back pain. The scientists injected MSCs directly into the degenerating vertebral disks of patients suffering from lower back pain, resulting in an overall reduction in the mean pain score, improved function for at least 12 months, and a reduced need for further surgical and non-surgical treatment interventions.
Of the 6 million Americans suffering from debilitating back pain today, 3.5 million are affected by degenerative invertebral disk disease. The results of this clinical trial show that, instead of addressing the symptoms, mesenchymal stem cells are able to treat the source of the pain for long lasting relief. According to lead researcher, Dr. Tory McJunkin, M.D, “This study shows we are progressing toward major advances in pain medicine,”
Mesenchymal stem cells have the unique capacity to regenerate a multitude of different types of tissues – such as neurons, insulin producing pancreatic beta cells, bone, cartilage, and cardiomyocites amongst them. This Phase II study is just one example of the utility of stem cells in successfully treating conditions previously thought to be untreatable or treatable only through invasive options. To learn how to bank your own valuable stem cells to insure access to emerging regenerative therapies, visit www.stemsave.com or call 877-783-6728 877-StemSave) today.
Researchers from the UNSW Graduate School of Biomedical Engineering, Ludwig Maximilians University, Case Western Reserve University, and the Cleveland Clinic have identified a source of autologous [the patient’s own] stem cells, called periosteum-derived stem cells [PDSC], which reside in the discarded tissue resulting from hip replacement surgery. Continue reading
Researchers from the Institute for Ophthalmology at the University College of London report on a significant advancement in stem cell therapy that can potentially lead to new treatments for blindness. Adult stem cells were manipulated into rod cells and then injected into blind animal models, partially restoring the vision of the animals. Continue reading
A research team from Aston University has developed a new method to investigate Alzheimer’s disease through the use of human stem cells. Through the study of tau proteins, this novel use of stem cells can help scientists predict with greater accuracy the effectiveness of different treatments to prevent the onset of Alzheimer’s disease. Continue reading
Researchers at the Samsung Medical Center and Biomedical Research Institute in Seoul, South Korea, have succeeded in treating and preventing Bronchopulmonary Dysplasia [BPD], a chronic lung disease affecting preterm infants. In a Phase 1 clinical trial, the research team was successful in transplanting mesenchymal stem cells to repair damage and underdevelopment within the infant’s lungs. Continue reading
A medical team from the University of Calgary is now recruiting candidates to participate in the phase one clinical trial for a new stem cell therapy that aims to treat spinal cord injuries. The researchers plan to inject stem cells into the spinal cord two sites above and two sites below the point of injury to recreate lost or damaged tissue. Continue reading
A team of researchers led by Dr. Gordana Vunjak-Novakovic [a member of StemSave’s Scientific Advisory Council] has engineered a scaffold to facilitate the regeneration of heart muscle through the use of adult stem cells. In an animal model, Vunjak-Novakovic and her team created a scaffold using biodegradable chitosan and carbon nanofibers, infusing it with stem cells to provoke the regeneration of beating cardiomyocytes. Continue reading
Molecular Biologists from Genentech, Inc., in California have utilized stem cells to better understand the advent and growth of prostate cancer. The researchers discovered a marker specific to cancerous cells that, when used as a therapeutic target, could lead to the development of new prostate cancer treatments. Continue reading